• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

斯德哥尔摩前列腺癌检测的时空变化:一项基于人群的研究。

Spatio-temporal variation in prostate cancer testing in Stockholm: A population-based study.

机构信息

Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden.

Department of Sociology and Social Work, Aalborg University, Aalborg Øst, Denmark.

出版信息

PLoS One. 2024 Aug 15;19(8):e0308254. doi: 10.1371/journal.pone.0308254. eCollection 2024.

DOI:10.1371/journal.pone.0308254
PMID:39146336
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11326630/
Abstract

Prostate cancer screening using prostate-specific antigen (PSA) testing is controversial but remains prevalent in many countries. There is little information in Sweden or elsewhere on the spatial variation in PSA testing. This study aims to describe the spatio-temporal variation in PSA testing prior to a prostate cancer diagnosis in the Stockholm region at the municipality and small area levels. A population-based register study comprised men aged 40 years and over living in the Stockholm region during 2007-2016. For Stockholm in 2016, we reported the proportion of men who had a PSA test for the preceding one, two, five and ten years by ten-year age groups. The age-standardised proportion of men having a PSA test was reported for municipalities by calendar years. We used spatial smoothing for calculating the age-standardised proportion of men having a PSA test in a small area for each calendar year. In 2016, 74.0% and 77.8% of men aged 60-69 and 70-79 years respectively had taken a PSA test in the previous ten years. The municipalities of Danderyd and Ekerö showed high proportions of PSA testing. A marked heterogeneity in such proportions within each municipality was observed. The odds ratio for having a PSA test for those born in Sweden was 2.22 (95% CI 2.00-2.52). Opportunistic PSA testing is widespread with three quarters of men in their sixties and seventies having had a test in the preceding decade. We found evidence for marked geographical heterogeneity, where more affluent and metropolitan areas had higher levels of testing. Variations in PSA testing was associated with socio-economic position and demographic factors including education, income and country of birth.

摘要

使用前列腺特异性抗原(PSA)检测进行前列腺癌筛查存在争议,但在许多国家仍然普遍存在。瑞典或其他地方关于 PSA 检测的空间变化的信息很少。本研究旨在描述斯德哥尔摩地区在前列腺癌诊断前 PSA 检测的时空变化,在市和小区域两级进行。一项基于人群的登记研究包括 2007-2016 年间居住在斯德哥尔摩地区的 40 岁及以上的男性。对于 2016 年的斯德哥尔摩,我们报告了前一年、两年、五年和十年中每十年年龄组接受 PSA 检测的男性比例。按历年报告了各市的 PSA 检测男性的年龄标准化比例。我们使用空间平滑来计算每个历年小区域内接受 PSA 检测的男性的年龄标准化比例。2016 年,分别有 74.0%和 77.8%的 60-69 岁和 70-79 岁男性在前十年接受过 PSA 检测。Danderyd 和 Ekerö 这两个市的 PSA 检测比例较高。在每个市中,这种比例都存在明显的异质性。出生在瑞典的男性接受 PSA 检测的比值比为 2.22(95%CI 2.00-2.52)。机会性 PSA 检测很普遍,四分之三的六七十岁男性在前十年接受过检测。我们发现存在明显的地理异质性,较富裕和大都市区的检测水平较高。PSA 检测的变化与社会经济地位和人口因素有关,包括教育、收入和出生国。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5df6/11326630/09acc13dea82/pone.0308254.g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5df6/11326630/779e32362f7f/pone.0308254.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5df6/11326630/5d9c8e04a238/pone.0308254.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5df6/11326630/747cff602835/pone.0308254.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5df6/11326630/9a3e46961500/pone.0308254.g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5df6/11326630/729769a83164/pone.0308254.g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5df6/11326630/09acc13dea82/pone.0308254.g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5df6/11326630/779e32362f7f/pone.0308254.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5df6/11326630/5d9c8e04a238/pone.0308254.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5df6/11326630/747cff602835/pone.0308254.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5df6/11326630/9a3e46961500/pone.0308254.g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5df6/11326630/729769a83164/pone.0308254.g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5df6/11326630/09acc13dea82/pone.0308254.g006.jpg

相似文献

1
Spatio-temporal variation in prostate cancer testing in Stockholm: A population-based study.斯德哥尔摩前列腺癌检测的时空变化:一项基于人群的研究。
PLoS One. 2024 Aug 15;19(8):e0308254. doi: 10.1371/journal.pone.0308254. eCollection 2024.
2
Prostate-specific antigen (PSA) testing is prevalent and increasing in Stockholm County, Sweden, Despite no recommendations for PSA screening: results from a population-based study, 2003-2011.前列腺特异性抗原(PSA)检测在瑞典斯德哥尔摩县普遍存在且呈上升趋势,尽管没有推荐用于 PSA 筛查:一项基于人群的研究结果,2003-2011 年。
Eur Urol. 2013 Mar;63(3):419-25. doi: 10.1016/j.eururo.2012.10.001. Epub 2012 Oct 12.
3
Poor Follow-up After Elevated Prostate-specific Antigen Tests: A Population-based Cohort Study.前列腺特异性抗原检测升高后的随访不佳:一项基于人群的队列研究。
Eur Urol Focus. 2019 Sep;5(5):842-848. doi: 10.1016/j.euf.2018.02.001. Epub 2018 Feb 9.
4
Association Between Antidiabetic Medications and Prostate-Specific Antigen Levels and Biopsy Results.抗糖尿病药物与前列腺特异性抗原水平及活检结果的相关性。
JAMA Netw Open. 2019 Nov 1;2(11):e1914689. doi: 10.1001/jamanetworkopen.2019.14689.
5
Opportunistic testing versus organized prostate-specific antigen screening: outcome after 18 years in the Göteborg randomized population-based prostate cancer screening trial.机会性检测与有组织的前列腺特异性抗原筛查:哥德堡随机人群前列腺癌筛查试验 18 年后的结果。
Eur Urol. 2015 Sep;68(3):354-60. doi: 10.1016/j.eururo.2014.12.006. Epub 2014 Dec 31.
6
Uptake of prostate-specific antigen testing for early prostate cancer detection in Sweden.瑞典开展前列腺特异性抗原检测以早期发现前列腺癌。
Int J Cancer. 2011 Oct 15;129(8):1881-8. doi: 10.1002/ijc.25846. Epub 2011 Mar 25.
7
Prostate cancer screening practices in a large, integrated health system: 2007-2014.大型综合医疗系统中的前列腺癌筛查实践:2007 - 2014年
BJU Int. 2017 Aug;120(2):257-264. doi: 10.1111/bju.13793. Epub 2017 Feb 26.
8
Prostate cancer screening using a combination of risk-prediction, MRI, and targeted prostate biopsies (STHLM3-MRI): a prospective, population-based, randomised, open-label, non-inferiority trial.使用风险预测、MRI 和靶向前列腺活检的组合进行前列腺癌筛查(STHLM3-MRI):一项前瞻性、基于人群、随机、开放标签、非劣效性试验。
Lancet Oncol. 2021 Sep;22(9):1240-1249. doi: 10.1016/S1470-2045(21)00348-X. Epub 2021 Aug 13.
9
Influence of blood prostate specific antigen levels at age 60 on benefits and harms of prostate cancer screening: population based cohort study.60 岁时血液前列腺特异性抗原水平对前列腺癌筛查的获益和危害的影响:基于人群的队列研究。
BMJ. 2014 Mar 28;348:g2296. doi: 10.1136/bmj.g2296.
10
A population-based study on the association between educational length, prostate-specific antigen testing and use of prostate biopsies.一项基于人群的关于教育年限、前列腺特异性抗原检测与前列腺活检使用之间关联的研究。
Scand J Urol. 2016;50(2):104-9. doi: 10.3109/21681805.2015.1113200. Epub 2015 Dec 1.

本文引用的文献

1
Spatial patterns of prostate-specific antigen testing in asymptomatic men across Australia: a population-based cohort study, 2017-2018.2017 - 2018年澳大利亚无症状男性前列腺特异性抗原检测的空间模式:一项基于人群的队列研究
Public Health. 2023 Apr;217:173-180. doi: 10.1016/j.puhe.2023.01.039. Epub 2023 Mar 8.
2
Changes in prostate specific antigen (PSA) "screening" patterns by geographic region and socio-economic status in Australia: Analysis of medicare data in 50-69 year old men.澳大利亚不同地理区域和社会经济地位下前列腺特异性抗原(PSA)“筛查”模式的变化:对 50-69 岁男性医疗保险数据的分析。
Cancer Epidemiol. 2023 Apr;83:102338. doi: 10.1016/j.canep.2023.102338. Epub 2023 Feb 24.
3
Designing and Implementing a Population-based Organised Prostate Cancer Testing Programme.
设计并实施一项基于人群的有组织的前列腺癌检测计划。
Eur Urol Focus. 2022 Nov;8(6):1568-1574. doi: 10.1016/j.euf.2022.06.008. Epub 2022 Jul 8.
4
Prostate cancer screening using a combination of risk-prediction, MRI, and targeted prostate biopsies (STHLM3-MRI): a prospective, population-based, randomised, open-label, non-inferiority trial.使用风险预测、MRI 和靶向前列腺活检的组合进行前列腺癌筛查(STHLM3-MRI):一项前瞻性、基于人群、随机、开放标签、非劣效性试验。
Lancet Oncol. 2021 Sep;22(9):1240-1249. doi: 10.1016/S1470-2045(21)00348-X. Epub 2021 Aug 13.
5
Short-term effects of air pollutants on daily mortality in the Stockholm county - A spatiotemporal analysis.短期空气污染物对斯德哥尔摩县每日死亡率的影响-时空分析。
Environ Res. 2020 Sep;188:109854. doi: 10.1016/j.envres.2020.109854. Epub 2020 Jun 27.
6
PSA testing patterns in a large Swedish cohort before the implementation of organized PSA testing.在实施有组织的 PSA 检测之前,在一个大型瑞典队列中进行 PSA 检测的模式。
Scand J Urol. 2020 Oct;54(5):376-381. doi: 10.1080/21681805.2020.1797871. Epub 2020 Jul 31.
7
Epidemiology of Prostate Cancer.前列腺癌流行病学
World J Oncol. 2019 Apr;10(2):63-89. doi: 10.14740/wjon1191. Epub 2019 Apr 20.
8
Prostate cancer screening with prostate-specific antigen (PSA) test: a systematic review and meta-analysis.前列腺癌筛查中前列腺特异性抗原(PSA)检测的系统评价和荟萃分析。
BMJ. 2018 Sep 5;362:k3519. doi: 10.1136/bmj.k3519.
9
Screening for Prostate Cancer: US Preventive Services Task Force Recommendation Statement.前列腺癌筛查:美国预防服务工作组推荐声明。
JAMA. 2018 May 8;319(18):1901-1913. doi: 10.1001/jama.2018.3710.
10
Poor Follow-up After Elevated Prostate-specific Antigen Tests: A Population-based Cohort Study.前列腺特异性抗原检测升高后的随访不佳:一项基于人群的队列研究。
Eur Urol Focus. 2019 Sep;5(5):842-848. doi: 10.1016/j.euf.2018.02.001. Epub 2018 Feb 9.